These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Cardiac valvulopathy and dopamine agonist]. Grandas F Neurologia; 2007 Dec; 22(10):870-81. PubMed ID: 17671852 [TBL] [Abstract][Full Text] [Related]
13. [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide]. van Laar T; Berendse H; Bloem BR; Boon AJ; van Hilten JJ; Hovestadt A; de Koning-Tijssen MA; Nijssen PC; Weber WE Ned Tijdschr Geneeskd; 2009 Jan; 153(3):87-90. PubMed ID: 19235345 [No Abstract] [Full Text] [Related]
15. Drug-related valvular heart disease: here we go again: will we do better this time? Rahimtoola SH Mayo Clin Proc; 2002 Dec; 77(12):1275-7. PubMed ID: 12479510 [No Abstract] [Full Text] [Related]
16. [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use]. van Strater AC; Bax JJ; van Hilten JJ; Jukema JW Ned Tijdschr Geneeskd; 2005 Apr; 149(16):891-4. PubMed ID: 15868996 [TBL] [Abstract][Full Text] [Related]
18. Pergolide associated cardiac valvulopathy based on Ontario administrative data. Zadikoff C; Duong-Hua M; Sykora K; Marras C; Lang A; Rochon P Can J Neurol Sci; 2008 May; 35(2):173-8. PubMed ID: 18574930 [TBL] [Abstract][Full Text] [Related]
19. Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists. Lledó A; Dellva MA; Strombom IM; Wilkie JL; Jungemann ME; Royer MG; Simmons VE; Cavazzoni PA Eur J Neurol; 2007 Jun; 14(6):644-9. PubMed ID: 17539942 [TBL] [Abstract][Full Text] [Related]
20. New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance. Rascol O; Pathak A; Bagheri H; Montastruc JL Mov Disord; 2004 Jun; 19(6):611-3. PubMed ID: 15197697 [No Abstract] [Full Text] [Related] [Next] [New Search]